The estimated Net Worth of Istvan Molnar is at least $2.64 Milion dollars as of 4 March 2021. Istvan Molnar owns over 4,027 units of Lantheus Inc stock worth over $2,562,004 and over the last 5 years he sold LNTH stock worth over $74,097. In addition, he makes $0 as Chief Medical Officer at Lantheus Inc.
Sign up
Istvan Molnar LNTH stock SEC Form 4 insiders trading
Istvan has made over 1 trades of the Lantheus Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 4,027 units of LNTH stock worth $74,097 on 4 March 2021.
The largest trade he's ever made was selling 4,027 units of Lantheus Inc stock on 4 March 2021 worth over $74,097. On average, Istvan trades about 2,014 units every 0 days since 2020. As of 4 March 2021 he still owns at least 25,130 units of Lantheus Inc stock.
You can see the complete history of Istvan Molnar stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Istvan Molnar biography
Dr. Istvan Molnar serves as Chief Medical Officer of the Company since January 2019. Dr. Molnar is an oncologist with over 12 years of experience in the pharmaceutical industry and the development of early-, mid- and late-stage oncology drugs. Most recently, Dr. Molnar served as Chief Medical Officer of Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for the treatment of cancer. Previously, he served as Vice President of Development at Merrimack Pharmaceuticals for 3 years, where he was responsible for development in the liposomal franchise. Prior to his role at Merrimack, Dr. Molnar worked at Bayer HealthCare for almost 7 years, serving in several roles, including Deputy Director of Global Medical Affairs, Director of Global Medical Affairs, Director of Clinical Development/Global Clinical Lead. Before starting his career in the pharmaceutical industry, Dr. Molnar practiced medicine as an internist for 3 years. After completing his fellowship in hematology and oncology at the Wake Forest University School of Medicine, Dr. Molnar became an Assistant Professor at the University, focusing on the care of patients with hematological malignancies for 5 years. Dr. Molnar earned his MD from Semmelweis Medical School in Budapest and achieved board certification in the United States in internal medicine, hematology and oncology.
How old is Istvan Molnar?
Istvan Molnar is 53, he's been the Chief Medical Officer of Lantheus Inc since 2019. There are 16 older and 8 younger executives at Lantheus Inc. The oldest executive at Lantheus Holdings Inc is James Thrall, 76, who is the Independent Director.
What's Istvan Molnar's mailing address?
Istvan's mailing address filed with the SEC is C/O LANTHEUS HOLDINGS, INC., 331 TREBLE COVE ROAD, NORTH BILLERICA, MA, 01862.
Insiders trading at Lantheus Inc
Over the last 9 years, insiders at Lantheus Inc have traded over $500,725,766 worth of Lantheus Inc stock and bought 8,000 units worth $141,200 . The most active insiders traders include David F Burgstahler, Capital Partners Gp, Llc Av... a Sriram Venkataraman. On average, Lantheus Inc executives and independent directors trade stock every 11 days with the average trade being worth of $15,777,680. The most recent stock trade was executed by James H Thrall on 21 August 2024, trading 1,000 units of LNTH stock currently worth $98,520.
What does Lantheus Inc do?
lantheus holdings, inc. (nasdaq: lnth) is the parent company of lantheus medical imaging, inc. (lmi), which is a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products. lmi provides a broad portfolio of products, which are primarily used for the diagnosis of cardiovascular diseases. lmi’s key products include the echocardiography contrast agent definity® vial for (perflutren lipid microsphere) injectable suspension; technelite® (technetium tc99m generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; and xenon (xenon xe 133 gas), an inhaled radiopharmaceutical imaging agent used to evaluate pulmonary function and for imaging the lungs. the company is headquartered in north billerica, massachusetts with offices in puerto rico and canada. for more information, visit www.lantheus.com.
What does Lantheus Inc's logo look like?
Complete history of Istvan Molnar stock trades at Lantheus Inc
Lantheus Inc executives and stock owners
Lantheus Inc executives and other stock owners filed with the SEC include:
-
Mary Heino,
President, Chief Executive Officer, Director -
Robert Marshall,
Chief Financial Officer, Treasurer -
Mary Anne Heino,
CEO, Pres & Director -
Michael Duffy,
Senior Vice President, Law and Public Policy and General Counsel -
John Bolla,
Chief Operating Officer, Senior Vice President, Technical Operations -
Simon Robinson,
Senior Vice President - Research and Pharmaceutical Development -
Robert J. Marshall Jr., CFA,
CFO & Treasurer -
Paul M. Blanchfield,
Chief Operating Officer -
Daniel M. Niedzwiecki,
Sr. VP, Gen. Counsel & Corp. Sec. -
Brian Markison,
Non-Executive Independent Chairman of the board -
Samuel Leno,
Independent Director -
Frederick Robertson,
Independent Director -
James Clemmer,
Independent Director -
Gary Pruden,
Independent Director -
Julie McHugh,
Independent Director -
James Thrall,
Independent Director -
Heinz Maeusli,
Independent Director -
Gerard Ber,
Independent Director -
Istvan Molnar,
Chief Medical Officer -
Paul Blanchfield,
Chief Commercial Officer -
Carol Walker,
Senior Vice President - Quality -
Etienne Montagut,
Senior Vice President - Corporate Development -
Etienne Montagut,
Chief Bus. Officer -
Carol Walker,
Sr. VP of Quality -
Ying Yao,
Chief HR Officer -
Melissa Downs,
Director of Corp. Communications -
Linda S. Lennox,
VP of Corp. Communications & Chief of Staff -
Mark Richard Kinarney,
Sr. Director of Investor Relations -
Andrea Sabens,
Principal Accounting Officer -
Capital Partners Gp, Llc Av...,
-
David F Burgstahler,
Director -
Cesare Orlandi,
Chief Medical Officer -
Derace L Schaffer,
Director -
Sriram Venkataraman,
Director -
Timothy G Healey,
SVP, Commercial -
Daniel Niedzwiecki,
See Remarks -
Ying Vivian Yao,
Chief Human Resources Officer -
Minnie Baylor Henry,
-
Andrea Sabens,
Chief Accounting Officer -
Kenneth Pucel,
Director -
John W. Crowley,
VP Finance and Accounting -
John K Bakewell,
CFO and Treasurer -
Patrick O'neill,
Director -
William C. Jr. Dawes,
VP Mfrg and Operations -
Jeffrey Allen Bailey,
CEO and President -
Kimberly Brown,
Chief Accounting Officer -
Jeffrey Humphrey,
Chief Medical Officer -
Sam R Leno,
-
Jean Claude Provost,
Chief Medical Officer